Mometasone Furoate

Overview

Mometasone Furoate is a synthetic corticosteroid with anti-inflammatory and antipruritic properties. It is commonly used in the treatment of skin conditions and allergic rhinitis.

API suppliers (24)

Suppliers of Mometasone Furoate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• AARTI PHARMALABS LIMITEDIndia4 active DMF
• WAVELENGTH ENTERPRISES LTDIsrael2 active DMF GMP on record
• NEWCHEM SPAItaly2 active DMF GMP on record
• STERLING SPAItaly2 active DMF GMP on record
• Cipla USA, Inc.USA2 active DMF
• TIANJIN TIANYAO PHARMACEUTICALS CO LTDChina2 active DMF
• SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD2 active DMF
• CORAL DRUGS PRIVATE LTD2 active DMF GMP on record
• CURIA SPAIN SAUSpain1 active DMF GMP on record
• SYMBIOTICA SPECIALITY INGREDIENTS SDN BHDMalaysia1 active DMF
• CORAL DRUGS PVT LTDIndia1 active DMF GMP on record
• Hovione FarmaCiencia SAPortugal1 active DMF GMP on record
• TAPI NL BVNetherlands1 active DMF
• SYMBIOTEC PHARMALAB PRIVATE LTDIndia1 active DMF GMP on record
• SYMBIOTEC PHARMALAB LTD1 active DMF GMP on record
• Aurisco Pharmaceutical Co.,ltdChina1 active DMF GMP on record
• HALCYON LABS PRIVATE LTDIndia1 active DMF
• Taro Pharmaceutical Industries Ltd.Israel1 active DMF GMP on record
• BREATHGREEN PHARMACEUTICAL CO LTD1 active DMF
• FARMABIOS SPAItaly1 active DMF
• INDUSTRIALE CHIMICA SRLItaly1 active DMF GMP on record
• HENAN LIHUA PHARMACEUTICAL CO LTD1 active DMF
• HUNAN YUXIN PHARMACEUTICAL CO LTD
• Cipla LimitedIndiaCEP GMP on record

EU CEP holders (11)

Companies holding a valid EU Certificate of Suitability (CEP) for Mometasone Furoate, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Patent & exclusivity (US)

Per the FDA Orange Book (21 approved US products), the latest listed US patent on Mometasone Furoate expires 24 Nov 2034. Generic API sourcing typically opens up once these lapse.

Therapeutic areas